MAP vs NUZ

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

MAP

MICROBA FPO [MAP]

41LOW

NUZ

NEURITHERA FPO [NUZ]

41LOW

Score Breakdown

MAP NUZ
Technical
68
48
Catalyst
58
53
Sentiment
50
50
Fundamental
54
43
Momentum
27
36
Risk Gate
45
50

Key Metrics

MAP Metric NUZ
$28.7MMarket Cap$51.2M
1.5MAvg Volume (20d)1.1M
N/AShort InterestN/A
$0.10552-Week High$0.185
$0.03652-Week Low$0.055
-9.8%Daily Change-3.0%
$0.037Reference Price$0.065
-60.0%ROE-147.1%
-132.5%Profit Margin-248.4%

Active Signals

MAP Signals

●RSI drifting toward oversold territory — worth watching
●Bollinger Bands are tightening — volatility is coiling up for a potential breakout
●Trading below both moving averages — the trend is working against this one
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Sitting near support — this level has held before and could attract buyers again
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it

NUZ Signals

●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.8 quarters)
●Moderate P/S ratio (8.6x)
●Strong revenue growth (+290%)
●Near 52-week low (9% of range)
●Small-cap ($20-100M)
●Capital raise activity (1 events)
●Deeply negative margins (-248%)

Ask Scout AI to compare MAP and NUZ in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

CYC vs MAP →CYC vs NUZ →HIQ vs OSL →MAP vs OSL →NUZ vs OSL →
MAP Full Analysis → NUZ Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).